MML Investors Services
LPCN icon

MML Investors Services’s Lipocine LPCN Stock Holding History

MML Investors Services’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,529
Closed -$24K – 2327
2023
Q1 		$24K Hold
4,529
– – ﹤0.01% 2010
2022
Q4 		$31K Hold
4,529
– – ﹤0.01% 2135
2022
Q3 		$35K Hold
4,529
– – ﹤0.01% 2054
2022
Q2 		$62K Hold
4,529
– – ﹤0.01% 1999
2022
Q1 		$105K Hold
4,529
– – ﹤0.01% 2018
2021
Q4 		$76K Buy
4,529
+1,470
+48% +$27.3K ﹤0.01% 1987
2021
Q3 		$57K Buy
3,059
+353
+13% +$7.79K ﹤0.01% 1934
2021
Q2 		$64K Buy
2,706
+294
+12% +$6.91K ﹤0.01% 1881
2021
Q1 		$62K Buy
+2,412
New +$69.6K ﹤0.01% 1783

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MML Investors Services's LPCN Position: Q2 2023 in Review

MML Investors Services sold out of Lipocine (LPCN) in Q2 2023, closing a stake of 4,529 shares — an estimated $24K sold.

MML Investors Services first reported a position in LPCN in Q1 2021 and held it in 9 quarters. The position peaked at $105K in Q1 2022. 24 funds tracked by Wall St. Rank hold LPCN as of Q2 2023.

  • MML Investors Services reported no remaining Lipocine position as of Q2 2023 after selling out during the quarter.
  • MML Investors Services sold 4,529 Lipocine shares in Q2 2023, an estimated $24K.
  • MML Investors Services first reported a position in Lipocine in Q1 2021 and held it in 9 quarters.
  • MML Investors Services's Lipocine position peaked at $105K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Lipocine as of Q2 2023.

Based on MML Investors Services's 13F filing for Q2 2023, filed 14 Aug 2023.